Arkolith/Insider Trading/MYMD/Form 4

Schreiber Christopher C

DirectorMyMD Pharmaceuticals, Inc. (MYMD) · full profile →Form 4 · filed Apr 21, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 16, 2021Option exercise(M)132K——134K
Apr 16, 2021Tax withholding(F)46K$4.94$228K88K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 16, 2021Option exercise(M)132K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-009398) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML